Carbamic Acid

Carbamic Acid

SCHEMBL9949893

NC(=O)O.Nc1ccc(C(=O)O)c(Cl)c1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 3/20 0.59
TSHR P16473 3/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
ALDH1A1 P00352 6/20 0.57
CYP3A4 P08684 6/20 0.57
MAPT P10636 5/20 0.57
KDM4E B2RXH2 3/20 0.57
GAA P10253 1/20 0.57
ESR2 Q92731 1/20 0.57
PTPN1 P18031 1/20 0.57
THRB P10828 3/20 0.52
RECQL P46063 3/20 0.52
TDP1 Q9NUW8 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HPGD P15428 2/20 0.52
ALOX15 P16050 2/20 0.52
HSD17B10 Q99714 2/20 0.52
POLB P06746 2/20 0.52
USP2 O75604 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL99697 0.96 CASP1 (0.63) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL11630591 0.94 CASP1 (0.61) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL7218589 0.85 CASP1 (0.47) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL2335079 0.83 KMT2A (0.55) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL10434174 0.81 MAPT (0.59) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
Thiosalicylic Acid SCHEMBL4554104 0.81 MAPT (0.59) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL7090488 0.81 JAK2 (0.53) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL28610796 0.81 TSHR (0.57) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
Aminosalicylic Acid SCHEMBL5070587 0.80 ALDH1A1 (0.67) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL11630588 0.79 JAK2 (0.51) CASP1TSHRSMN1; SMN2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165315-A1 MEPTAZINOL CARBAMATE PRODRUG SALTS JOSTENS, INC. 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165315-A1 MEPTAZINOL CARBAMATE PRODRUG SALTS MEP1A, MEP1B, CTSZ CASP1 688/4885TSHR 2125/4885SMN1; SMN2 3945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.